Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.3.0.15
Consolidated Balance Sheets (USD $)
Sep. 30, 2011
Dec. 31, 2010
Current Assets:    
Cash and cash equivalents $ 0 $ 54,000
Prepaid expenses 343,000 83,000
Total Current Assets 343,000 137,000
Patents, net 28,000 48,000
Total Other Assets 28,000 48,000
TOTAL ASSETS 371,000 185,000
Current Liabilities:    
Accounts payable 974,000 625,000
Accrued interest 1,614,000 1,439,000
Accrued expenses 557,000 414,000
Warrant liability 290,000 1,012,000
Demand notes payable, net of discount of $53,000 and $0 198,000 205,000
Convertible debentures, net of discount of $0 and $250,000, current portion 505,000 415,000
Convertible debentures 1,139,000 1,544,000
Total Current Liabilities 5,277,000 5,654,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively 1,000 1,000
Series H – 25,000 and 25,000 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively 0 0
Series I – 1,666,667 and 1,666,667 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; 238,622,616 and 149,571,976 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively 239,000 149,000
Additional paid-in capital 77,509,000 74,474,000
Accumulated deficit (82,657,000) (80,095,000)
Total Stockholders' Deficit (4,906,000) (5,469,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 371,000 $ 185,000